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Diabetes remains a major burden in health care both                 
in developed and developing countries. Kalanchoe pinnata              
has been used as a traditional medicine to treat diabetes. The 
aim of this study to find scientific evidence of antidiabetic    
activity of Kalanchoe pinnata extract (KPE) through hypoglycemic 
effect using animal model of diabetes mellitus. Hyperglycaemia 
was developed in rats using alloxan 150mg/kgBW. Three                
days after alloxan injection, rats having fasting blood glucose 
(FBG) >200mg/dL were divided into six groups, namely                   
HG (hyperglycaemia), HG+KPE high-dose (hyperglycaemia+            
KPE 33.2mg/kg), HG+KPE  medium-dose (hyperglycaemia+           
KPE 11.6mg/kg), HG+KPE low-dose (hyperglycaemia+                 
KPE 5.8mg/kg), standard drug 1 (hyperglycaemia+glibenclamide 
1.35mg/kg), standard drug 2 (hyperglycaemia+acarbose 
13.5mg/kg). Then, FBG was measured every 5 days recorded as 
t1, t2, and t3 to determine fluctuations in blood glucose. At the 
end of the study, rats were sacrified, pancreas was collected and 
number of pancreatic beta cell langerhans was determined. KPE 
11.6mg/kg showed best hypoglycemic effect and improvement of 
the number of pancreatic beta cell langerhans. KPE has 
hypoglycemic effect through improvement of the number of 
pancreatic beta cell langerhans but not in dose dependent 
manner.  
 




WHO (2015) reported 9% people aged 
18+ worldwide suffered from diabetes, while in 
Indonesia the prevalence was only 1.5% 
(Kemenkes RI, 2013). It is worth noticing that 
this disease is a burden of health care in both 
developed and developing countries (Abdulazeez 
et al., 2013). Diabetes develops from prolong 
glucose imbalance between intracellular and 
extracellular resulted in hyperglycaemia state in 
which blood glucose can not be utilized by 
living cells. These conditions lead to vascular 
complication through increasing oxidative stress 
and inflammation. Vascular complication is the 
leading cause of death in both diabetes type 
1and type 2 patient (Domingueti et al., 2015).  
Diabetes mellitus (DM) are classified as 
two major disease: type 1 DM and type 2 DM. 
Type 1 DM is an autoimmune disease that 
immune system of the body attack insulin 
producing pancreatic β cells resulting in low 
insulin production. This condition leads to 
insulin dependent DM. In the other hand, type 
2 DM was caused by inadequate action of 
insulin in action site (Hossain et al., 2016).  
Pharmacotheraphy in DM patient does 
not eliminate the cause of the disease but its 
targets on the symptom using insulin and 
hypoglicemic agent such as sulfonylurea and 
biguanids (Abdulazeez et al., 2013; Verma et al, 
2015). However, sulfonylurea exert several 
adverse effect such as hypoglicemia and weight 
gain, in addition to toxic effect on liver and 
renal, while metformin cause lactic acidosis 
(Verma et al., 2015).  
Alloxan is widely used in experimental 
pharmacology to induce diabetes in rat. The 
pathological mechanism is by destruction of 
insulin producing pancreatic β-cells. Alloxan 
undergo redox reaction resulted in increase 
increasing of radical species. In this case, 
pancreatic β-cells is the most sensitive organ 
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towards these radical attacks. Hyperglycaemia 
state does not occur immediately. At first, 
alloxan induces insulin release independent of 
glucose level. However, this effect is followed by 
suppression of the islet respons to even high level 
of glucose leading to hyperglycaemia state 
(Szkudelski et al., 2001).  
Nowadays, the need for safe and 
effective drugs has brought natural product as 
the promising source of companion drug for 
diabetes (Sharma and Gupta, 2015). Kalanchoe 
pinnata has been traditionally used worldwide as 
medicinal plants, including to treat diabetes 
(Patil et al., 2013). Our previous study reveals its 
antidiabetic activity through inhibition of               
α-glucosidase with IC50~16.12 ppm. 
Meanwhile, radical scavenger activity using 
DPPH method revealed IC50 ~29.61ppm of 
ethanol fraction, 23.15 ppm of buthanol 
fraction, and 17.27 ppm of ethyl acetic fraction 
(Indah et al., 2013).  
Therefore, current study aims to 
determine antidiabetic activity of ethanolic 
extract of Kalanchoe pinnata in alloxan-induced 
diabetic rats.  
 
MATERIALS AND METHODS  
Kalanchoe pinnata leaves were collected 
from Kawasan Puspiptek Serpong and were 
authenticated by Research Center for Biology, 
Indonesian Instititute of Sciences (LIPI).   
 
Preparation of plant extracts 
The leaves were dried using blower oven 
<50°C for 24h, crushed, and extracted using 
70% ethanol (3x24h maseration). Ethanol 
extracts obtained were then concentrated in 
rotary evaporator under vacuum. The yield of 
ethanolic extract of Kalanchoe pinnata (KP) dry 
leaves was 15.7%.  
 
Animals  
The Male Sprague Dawley rats (150-
350g) were procured from Fakultas Kedokteran 
Hewan IPB, Bogor and housed under standard 
conditions of temperature and relative humidity 
with 12h light/dark cycle. Animals were fed on 
standard commercial pellet diet and water ad 
libitum. The ethical clearance of the experiment 
has been approved by Health Research Ethics 
Commitee, Universitas Indonesia and Cipto 
Mangunkusumo Hospital, Indonesia (Ethical 
clearance certificate number: 663/UN2.F1/ 
ETIK/2016). 
 
Induction of diabetes  
Induction of diabetes was performed 
according to Misra and Aiman (2012), with 
modification. Base line FBG was measured 
before alloxan injection (t(-1)). Alloxan 
monohydrate (Sigma Aldrich; stored at 4°C) 
was dissolved in normal saline at room 
temperature (freshly prepared) and injected to 
30 overnight fasted male Sprague-Dawley rats 
at a dose of 150mg/kg intraperitonially. The 
animals were then kept for the next 7 days on 
10% glucose after alloxan administration. After 
72h of alloxan injection (t0), FBG was 
determined using GlucoDr glucometer strips. 
Animals with FBG >200mg/dL were 
considered to have developed experimental 
diabetes as shown by hyperglycaemia state. 
Then, FBG was measured every 5 days 
recorded as t1, t2, and t3 to determine 
fluctuations in FBG. Blood was collected from 
tail vein. As standard reference, Glibenclamide 
was given at a dose of 1.35mg/kg orally per 
day, while Acarbose was given at a dose of 
13.5mg/kg orally per day.  
 
Animal experimentation  
In the present study the animals           
were distributed into 7 groups (n=5) as    
follows:normal control, HG (hyperglycaemia), 
HG+KPE high-dose (hyperglycaemia+               
KPE 33.2mg/kg), HG+KPE medium-dose 
(hyperglycaemia+KPE 11.6mg/kg), HG+KPE 
low-dose (hyperglycaemia+KPE 5.8mg/kg), 
standard drug 1 (hyperglycaemia+ glibenclamide 
1.35mg/kg), standard drug 2 (hypergly-
caemia+acarbose 13.5mg/kg). The study was 
conducted for 15 days to evaluate the potential 
of the extracts to lower FBG level. Body 
weights of the rats were monitored weekly 
during the study period.    
 
Pancreas histological observation  
Pancreas histological observation was 
conducted on day 15, at the end of the 
experimental period. Rats were euthanized by 
ether and the pancreas were collected and fixed 
with bouin’s solution for 24h. The pancreas 
was then stained with Hematoxylin eosin (HE) for 
observation of number of beta cell Langerhans. 
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Statistical analysis 
Numeric data were expressed as mean ± 
SD. Data were analyzed using one-way analysis 
of variance (ANOVA) (p<0.05) followed by 
Multiple LSD.  
 
RESULTS DISCUSSION  
Base line FBG (t(-1)) was determined 
before alloxan injection. All rats showed 
normal FBG with no significant difference 
among the groups (Table I, Figure 1).  
Three days after alloxan injection (t0), 
hyperglycaemia state was confirmed by FBG 
>200mg/dL in all the rats. However, FBG 
increase was not significant in HG+KPE 
medium dose group and acarbose group 
compared to normal group. Meanwhile, no 
significantly difference was observed among 
groups that received alloxan injection.  
FBG reduction were detected after 5 
days (t1) alloxan injection in all groups.           
While 5 days treatment brought FBG to a        
level <200mg/dL in all groups, HG groups 
remained suffered from hyperglycaemia as         
shown by FBG >200mg/dL. As a result,           
only HG group differed significantly from 
normal group. In the other hand, all treatment 
reduced FBG significantly, but not high-dose 
KPE.    
Ten days after treatment (t2), all rats’ 
FBG kept decreasing. However, HG group 
remained in hyperglycaemia state as shown by 
FBG >200mg/dL. As a result, only HG group 
differed significantly from normal group and all 
treatments reduced FBG significantly.  
Fifteen days after treatment, all rats’ 
FBG went back to normal as shown by              
FBG <200mg/dL.   However,   only    standard  
treatment (glibenclamide or acarbose) reduced 
FBG similar to normal while KPE treatment 
did not reduced FBG significantly.   
Histological observation using HE 
staining showed that all treatment, but KPE 
high-dose, improved the morphology of β cells 
in comparison to the HG group based on the 
number of cell (Figure 2). However, only KPE 
medium and low dose increased the number of 
β cells significantly.  
K. pinnata has traditionally been used            
as medicinal plant to treat various ailments 
around the world, including diabetes (Patil et al., 
2013). Therefore, several study have been 
conducted to evaluate its bioactivity, such as 
antidiabetics, anticonvulsant,  antinociceptive, 
antiedematogenic, antiinflammatory, anticancer 
and antiHPV, antileishmanial (Patil et al.,           
2013; Mora-Perez et al., 2016; Ferreira et al., 
2014; Mahata et al., 2012; Muzitano et al.,  
2006).  
K. pinnata leaves contain anthocyanins 
that considered responsible for its antidiabetic, 
anticancer, cardiovascular, and neurological 
activity (Cruz et al., 2012). Anthocyanins are 
water soluble flavonoid compounds that gives 
color in plant (Cruz et al., 2012). 
Phytochemistry study of the KPE used in this 
study revealed flavonoids and steroids 
compound and isolated quercetin glycosides 
(Fajriyah, 2011).  
We suggest that the bioactivity of               
K. pinnata in reducing FBG and improving 
morphology of the islets of Langerhans              
and β cells were caused by its various               
natural compounds constituent, for example 
quercetin through antioxidant mechanism 
(Figure 3). 
Tabel I. Effect of KPE on FBG during study 
 
Group 
FBG± SD (mg/L) 
t (-1) To t1 t2 t3 
Normal 103.67±15.33 117.92±8.07 107.83±7.15 97.42±13.75 93.5±8.24 
HG 115±2.45 429±106.88 267±106.10 207±104.24 130±16.85 
HG+KPE (high dose)  112.2±12.76 384±137.48 174.6±111.84 111.2±24.22 116±13.93 
HG+KPE (medium dose)  112±10.05 259.4±48.53 134.4±30.00 115.8±17.88 116.2±10.40 
HG+KPE (low dose)  112.2±6.57 353.8±163.69 142.4±35.67 113.6±16.36 124.6±10.26 
HG+ Acarbose 109.5±16.99 262±36.79 121.83±22.25 105.67±14.51 97±8.65 
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Figure 1. Effect of KPE treatment on FBG level in alloxan induced rat. HG=Alloxan,               
KPE= Kalanchoe pinnata extract, high dose = 33.2mg/kg BW, medium dose= 11.6mg/kg BW,          
low dose= 5.8mg/kg BW, Glibenclamide = 1.35mg/kg bw, Acarbose = 13.5mg/kg BW. t(-1)                
=base line, t 0= after alloxan injection, t1 or t2 or t3 = 5 or 10 or 15 days after test sample 
administration. Data are expressed as mean ± SD. * & x, p < 0.05 (* indicates comparison between 




Figure 2. Effect of KPE treatment on number of pancreatic beta cell langerhans in alloxan induced 
rat. HG=Alloxan, KPE= Kalanchoe pinnata extract, high dose = 33.2 mg/kgbw, medium dose= 11.6 
mg/kg bw, low dose= 5.8 mg/kg bw, Glibenclamide = 1.35 mg/kg bw, Acarbose = 13.5 mg/kg 




Figure 3. Pancreatic β cell Langerhans stained with Hematoxylin eosin (HE). 
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It is worth noting that oxidative stress plays a 
role in the pathogenesis of diabetes mellitus. 
Hyperglycaemia was characterized with increase 
oxidative stress leading to defect in insulin 
action and insulin secretion. Quercetin as 
antioxidants reduced oxidative stress leading to 
protection of β cells of the pancreas resulted in 
the increase of insulin production and 
decreased of FBG. Several studies reported 
quercetin mechanism of action in diabetes such 
as decreases lipid peroxidation, increases 
antioxidant enzymes activity, inhibits insulin-
dependent activation of phosphoinositol-3-
kinase (PI-3K), and reduces intestinal glucose 
absorption by inhibiting GLUT (Sunarwidhi et 
al., 2014). 
Based on pharmacological and 
histopathological studies, we suggested that the 
hypoglycemic effect of KPE was optimum at 
medium dose (11.6mg/kg bw).  
However, it is difficult to conclude that 
hypoglycemic activity of KPE in this study is 
only caused by quercetin. Various active 
compounds in KPE may synergistically increase 
hypoglycemic effect.  
Therefore, the mechanism of action of 
each active compounds in the extract needs 
further investigation, including immuno 




This study showed that KPE possesed 
bioactivity in lowering blood glucose and 
improving the morphology of β cells  of 
Langerhans islet. KPE is potential to be 
developed as a blood glucose-lowering agent 
for diabetic patients.  
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